Growth hormone and HIV infection: Contribution to disease manifestations and clinical implications

Best Practice and Research: Clinical Endocrinology and Metabolism

Volumn 25, Issue 3, 2011, Pages 517-529

  Falutz, Julian ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

growth hormone deficiency; growth hormone resistance; HIV; lipodystrophy; truncal obesity; visceral adipose tissue; wasting

Indexed keywords

ANTIRETROVIRUS AGENT; GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR;

ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DYSLIPIDEMIA; GLUCOSE HOMEOSTASIS; GROWTH HORMONE DEFICIENCY; HORMONAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIPODYSTROPHY; METABOLIC DISORDER; OBESITY; QUALITY OF LIFE; WASTING SYNDROME;

EID: 79955003146     PISSN: 1521690X     EISSN: 15321908     Source Type: Journal    
DOI: 10.1016/j.beem.2010.11.001     Document Type: Review

References (83)

1. R. Hogg, V. Lima, and J. Sterne Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies Lancet 372 2008 293 299
2. J. Neuhaus, B. Angus, and J.D. Kowalska Risk of all-cause mortality associated with nonfatal AIDS and serious non-AIDS events among adults infected with HIV AIDS 24 2010 697 706
3. B. Marin, R. Thiebaut, and H.C. Bucher Non-AIDS-defining deaths and immunodeficiency in the era of combination antiretroviral therapy AIDS 23 2009 1743 1753
4. J. Falutz Therapy insight: body-shape changes and metabolic complications associated with HIV and highly active antiretroviral therapy Nature Clinical Practice Endocrinology Metabolism 3 2007 651 661 (Pubitemid 47294430)
5. I.B. Corless, K.M. Kirksey, and J. Kemppainen Lipodystrophy-associated symptoms and medication adherence in HIV/AIDS AIDS Patient Care and STDs 19 2005 577 586 (Pubitemid 41338913)
6. J.E. Ho, and P.Y. Hsue Cardiovascular manifestations of HIV infection Heart 95 2009 1193 1202
7. S. Grinspoon, and K. Mulligan Weight loss and wasting in patients infected with human immunodeficiency virus Clinical Infectious Disease 36 2003 S69 78
8. T.L. Stanley, and S.K. Grinspoon GH/GHRH axis in HIV lipodystrophy Pituitary 12 2009 143 152
9. D.E. Sellmeyer, and C. Grunfeld Endocrine and metabolic disturbances in human immunodeficiency virus infection and the acquired immune deficiency syndrome Endocrine Reviews 17 1996 518 532 (Pubitemid 26346641)
10. D.M. Wunder, N.A. Bersinger, and C.A. Fux Hypogonadism in HIV-1-infected men is common and does not resolve during antiretroviral therapy Antiviral Therapy 12 2007 261 265 (Pubitemid 46569911)
11. N.K. Lee, H. Sowa, and E. Hinoi Endocrine regulation of energy metabolism by the skeleton Cell 130 2007 456 469 (Pubitemid 47208519)
12. J.A. Barreto-Filho, M.R. Alcantara, and R. Salvatori Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia The Journal of Clinical Endocrinology and Metabolism 87 2002 2018 2023 (Pubitemid 34521484)
13. A. Mangili, D.H. Murman, and A.M. Zampini Nutrition and HIV infection: review of weight loss and wasting in the era of highly active antiretroviral therapy from the nutrition for healthy living cohort Clinical Infectious Disease 42 2006 836 842 (Pubitemid 43363942)
14. R. Heijligenberg, H.P. Sauerwein, and G. Brabant Circadian growth hormone secretion in asymptomatic human immune deficiency virus infection and acquired immunodeficiency syndrome The Journal of Clinical Endocrinology and Metabolism 81 1996 4028 4032 (Pubitemid 26380412)
15. L.D. Wilson, M.P. Truong, and A.R. Barber Anterior pituitary and pituitary-dependent target organ function in men infected with the human immunodeficiency virus Metabolism 45 1996 738 746 (Pubitemid 26176117)
16. R.A. Frost, J. Fuhrer, and R. Steigbigel Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system Clinical Endocrinology 44 1996 501 514 (Pubitemid 26168767)
17. L.F. Congote Monitoring insulin-like growth factors in HIV infection and AIDS Clinica Chimica Acta 361 2005 30 53 (Pubitemid 41382608)
18. S. Grinspoon, C. Corcoran, and T. Stanley Effects of androgen administration on the growth hormone-insulin-like growth factor I axis in men with acquired immunodeficiency syndrome wasting The Journal of Clinical Endocrinology and Metabolism 83 1998 4251 4256 (Pubitemid 29100117)
19. B.D. Rodgers Catabolic hormones and growth hormone resistance in acquired immunodeficiency syndrome and other catabolic states Proceedings of the Society for Experimental Biology and Medicine 212 1996 324 331
20. G. Johannsson, B.A. Bengtsson, and J. Ahlmen Double-blind, placebo-controlled study of growth hormone treatment in elderly patients undergoing chronic hemodialysis: anabolic effect and functional improvement American Journal of Kidney Disease 33 1999 709 717 (Pubitemid 29159937)
21. P. Kissmeyer-Nielsen, M.B. Jensen, and S. Laurberg Perioperative growth hormone treatment and functional outcome after major abdominal surgery: a randomized, double-blind, controlled study Annals of Surgery 229 1999 298 302 (Pubitemid 30191806)
22. A.J. Krentz, F.T. Koster, and D.M. Crist Anthropometric, metabolic, and immunological effects of recombinant human growth hormone in AIDS and AIDS-related complex Journal of Acquired Immune Deficiency Syndromes 6 1993 245 251 (Pubitemid 23099726)
23. T.R. Smith, J.S. Elmendorf, and T.S. David Growth hormone-induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4 The American Journal of Physiology 272 1997 E1071 1079
24. J. Svensson, and B.A. Bengtsson Growth hormone replacement therapy and insulin sensitivity The Journal of Clinical Endocrinology and Metabolism 88 2003 1453 1454 (Pubitemid 36636977)
25. M. Schambelan, K. Mulligan, and C. Grunfeld Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim study group Annals of Internal Medicine 125 1996 873 882
26. S.A. Lieberman, G.E. Butterfield, and D. Harrison Anabolic effects of recombinant insulin-like growth factor-I in cachectic patients with the acquired immunodeficiency syndrome The Journal of Clinical Endocrinology and Metabolism 78 1994 404 410 (Pubitemid 24061761)
27. P.D. Lee, J.M. Pivarnik, and J.G. Bukar A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection The Journal of Clinical Endocrinology and Metabolism 81 1996 2968 2975 (Pubitemid 26323894)
28. D. Waters, J. Danska, and K. Hardy Recombinant human growth hormone, insulin-like growth factor 1, and combination therapy in AIDS-associated wasting. A randomized, double-blind, placebo-controlled trial Annals of Internal Medicine 125 1996 865 872
29. K.J. Ellis, P.D. Lee, and J.M. Pivarnik Changes in body composition of human immunodeficiency virus-infected males receiving insulin-like growth factor I and growth hormone The Journal of Clinical Endocrinology and Metabolism 81 1996 3033 3038 (Pubitemid 26323904)
30. P.W. Mallon, J. Miller, and D.A. Cooper Prospective evaluation of the effects of antiretroviral therapy on body composition in HIV-1-infected men starting therapy AIDS 17 2003 971 979 (Pubitemid 36549708)
31. A.M. Tang, D.L. Jacobson, and D. Spiegelman Increasing risk of 5% or greater unintentional weight loss in a cohort of HIV-infected patients, 1995 to 2003 Journal of Acquired Immune Deficiency Syndromes 40 2005 70 76 (Pubitemid 41233208)
32. G.J. Moyle, E.S. Daar, and J.M. Gertner Growth hormone improves lean body mass, physical performance, and quality of life in subjects with HIV-associated weight loss or wasting on highly active antiretroviral therapy Journal of Acquired Immune Deficiency Syndromes 35 2004 367 375 (Pubitemid 38332797)
33. A. Carr, K. Samaras, and S. Burton A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors AIDS 12 7 1998 F51 F58
34. W. Khovidhunkit, M.S. Kim, and R.A. Memon Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host Journal of Lipid Research 45 2004 1169 1196 (Pubitemid 38802622)
35. J. Young, R. Weber, and M. Rickenbach Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study Antiviral Therapy 10 2005 585 591 (Pubitemid 41224950)
36. T.T. Brown, X. Li, and S.R. Cole Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the multicenter AIDS cohort study AIDS 19 2005 1375 1383 (Pubitemid 41800673)
37. M. Gerschenson, and K. Brinkman Mitochondrial dysfunction in AIDS and its treatment Mitochondrion 4 2004 763 777 (Pubitemid 39646821)
38. O. Miro, S. Lopez, and E. Martinez Mitochondrial effects of HIV infection on the peripheral blood mononuclear cells of HIV-infected patients who were never treated with antiretrovirals Clinical Infectious Disease 39 2004 710 716 (Pubitemid 39180445)
39. M. Caron-Debarle, C. Lagathu, and F. Boccara HIV-associated lipodystrophy: from fat injury to premature aging Trends in Molecular Medicine 16 2010 218 229
40. B. Zanone Poma, A. Riva, and M. Nasi Genetic polymorphisms differently influencing the emergence of atrophy and fat accumulation in HIV-related lipodystrophy AIDS 22 2008 1769 1778
41. P. Bacchetti, B. Gripshover, and C. Grunfeld Fat distribution in men with HIV infection Journal of Acquired Immune Deficiency Syndromes 40 2005 121 131 (Pubitemid 41395709)
42. J.L. Clasey, A. Weltman, and J. Patrie Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors The Journal of Clinical Endocrinology and Metabolism 86 2001 3845 3852 (Pubitemid 32755987)
43. P. Rietschel, C. Hadigan, and C. Corcoran Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy The Journal of Clinical Endocrinology and Metabolism 86 2001 504 510 (Pubitemid 32207451)
44. P. Koutkia, G. Meininger, and B. Canavan Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy American Journal of Physiology Endocrinology and Metabolism 286 2004 E296 303
45. P. Koutkia, B. Canavan, and J. Breu Growth hormone (GH) responses to GH-releasing hormone-arginine testing in human immunodeficiency virus lipodystrophy The Journal of Clinical Endocrinology and Metabolism 90 2005 32 38 (Pubitemid 40116630)
46. O. Andersen, S.B. Haugaard, and B.R. Hansen Different growth hormone sensitivity of target tissues and growth hormone response to glucose in HIV-infected patients with and without lipodystrophy Scandinavian Journal of Infectious Diseases 36 2004 832 839 (Pubitemid 40074018)
47. S. Benedini, I. Terruzzi, and A. Lazzarin Recombinant human growth hormone: rationale for use in the treatment of HIV-associated lipodystrophy BioDrugs 22 2008 101 112 (Pubitemid 351419122)
48. K.K. Miller, B.M. Biller, and J.G. Lipman Truncal adiposity, relative growth hormone deficiency, and cardiovascular risk The Journal of Clinical Endocrinology and Metabolism 90 2005 768 774 (Pubitemid 40279194)
49. M. Gola, S. Bonadonna, and M. Doga Clinical review: growth hormone and cardiovascular risk factors The Journal of Clinical Endocrinology and Metabolism 90 2005 1864 1870 (Pubitemid 40464062)
50. C. Beauregard, A.L. Utz, and A.E. Schaub Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: a randomized, placebo-controlled study The Journal of Clinical Endocrinology and Metabolism 93 2008 2063 2071 (Pubitemid 351831516)
51. K.C. Mekala, and N.A. Tritos Effects of recombinant human growth hormone therapy in obesity in adults: a meta analysis The Journal of Clinical Endocrinology and Metabolism 94 2009 130 137
52. N. Friis-Moller, C.A. Sabin, and R. Weber Combination antiretroviral therapy and the risk of myocardial infarction The New England Journal of Medicine 349 2003 1993 2003
53. K.A. Lichtenstein, C. Armon, and K. Buchacz Low CD4 + T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study Clinical Infectious Diseases 51 2010 435 447
54. K. Smith, L. Zheng, and R. Bosch Treatment with recombinant growth hormone is associated with modest improvement in CD4 lymphocyte reconstitution in HIV-infected persons on antiretroviral therapy: results of ACTG A5174 AIDS Research and Human Retroviruses 26 2010 425 432
55. D.A. Wohl, and T.T. Brown Management of morphologic changes associated with antiretroviral use in HIV-infected patients Journal of Acquired Immune Deficiency Syndromes 49 Suppl. 2 2008 S93 S100
56. J.C. Seidell, P. Bjorntorp, and L. Sjostrom Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels Metabolism 39 1990 897 901 (Pubitemid 20293933)
57. S. Bhasin, R.A. Parker, and F. Sattler Effects of testosterone supplementation on whole body and regional fat mass and distribution in human immunodeficiency virus-infected men with abdominal obesity The Journal of Clinical Endocrinology and Metabolism 92 2007 1049 1057 (Pubitemid 46465682)
58. C. Hadigan, C. Corcoran, and N. Basgoz Metformin in the treatment of HIV lipodystrophy syndrome: a randomized controlled trial Journal of American Medical Association 284 2000 472 477 (Pubitemid 30484481)
59. K. Mulligan, H. Khatami, and J.M. Schwarz The effects of recombinant human leptin on visceral fat, dyslipidemia, and insulin resistance in patients with human immunodeficiency virus-associated lipoatrophy and hypoleptinemia The Journal of Clinical Endocrinology and Metabolism 94 2009 1137 1144
60. W. Shen, Z. Wang, and M. Punyanita Adipose tissue quantification by imaging methods: a proposed classification Obesity Research 11 2003 5 16 (Pubitemid 41137532)
61. S. Klein, D.B. Allison, and S.B. Heymsfield Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: association for weight management and obesity prevention; NAASO, the Obesity Society; the American Society for nutrition; and the American Diabetes Association Diabetes Care 30 2007 1647 1652 (Pubitemid 46871194)
62. L.D. Plank Dual-energy X-ray absorptiometry and body composition Current Opinion in Clinical Nutrition and Metabolic Care 8 2005 305 309 (Pubitemid 40586190)
63. A. Misra, J.S. Wasir, and N.K. Vikram Waist circumference criteria for the diagnosis of abdominal obesity are not applicable uniformly to all populations and ethnic groups Nutrition 21 2005 969 976 (Pubitemid 41188097)
64. A.C. Carlsson, P.E. Wandell, and M. Halldin Is a unified definition of metabolic syndrome needed? Comparison of three definitions of metabolic syndrome in 60-year-old men and women Metabollic Syndrome and Related Disorders 7 2009 231 241
65. I. Lemieux, P. Poirier, and J. Bergeron Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology? The Canadian Journal of Cardiology 23 Suppl. B 2007 23B 31B (Pubitemid 47629137)
66. S. Mauss, E. Wolf, and H. Jaeger Reversal of protease inhibitor-related visceral abdominal fat accumulation with recombinant human growth hormone Annals of Internal Medicine 131 1999 313 314 (Pubitemid 29383666)
67. C. Wanke, J. Gerrior, and J. Kantaros Recombinant human growth hormone improves the fat redistribution syndrome (lipodystrophy) in patients with HIV AIDS 13 1999 2099 2103 (Pubitemid 29509587)
68. R.A. Torres, K.W. Unger, and J.A. Cadman Recombinant human growth hormone improves truncal adiposity and 'buffalo humps' in HIV-positive patients on HAART AIDS 13 1999 2479 2481
69. J.C. Lo, K. Mulligan, and M.A. Noor The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation The Journal of Clinical Endocrinology and Metabolism 86 2001 3480 3487 (Pubitemid 32761682)
70. V.W. Tai, M. Schambelan, and H. Algren Effects of recombinant human growth hormone on fat distribution in patients with human immunodeficiency virus-associated wasting Clinical Infectious Diseases 35 2002 1258 1262 (Pubitemid 35305875)
71. E.S. Engelson, M.J. Glesby, and D. Mendez Effect of recombinant human growth hormone in the treatment of visceral fat accumulation in HIV infection Journal of Acquired Immune Deficiency Syndromes 30 2002 379 391 (Pubitemid 34857312)
72. J.C. Lo, K. Mulligan, and M.A. Noor The effects of low-dose growth hormone in HIV-infected men with fat accumulation: a pilot study Clinical Infectious Diseases 39 2004 732 735 (Pubitemid 39180448)
73. A.G. Renehan, M. Zwahlen, and C. Minder Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis Lancet 363 2004 1346 1353 (Pubitemid 38529873)
74. D.P. Kotler, N. Muurahainen, and C. Grunfeld Effects of growth hormone on abnormal visceral adipose tissue accumulation and dyslipidemia in HIV-infected patients Journal of Acquired Immune Deficiency Syndromes 35 2004 239 252 (Pubitemid 38280649)
75. C. Grunfeld, M. Thompson, and S.J. Brown Recombinant human growth hormone to treat HIV-associated adipose redistribution syndrome: 12 week induction and 24-week maintenance therapy Journal of Acquired Immune Deficiency Syndromes 45 2007 286 297 (Pubitemid 47012375)
76. J. Lo, S.M. You, and B. Canavan Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial Journal of American Medical Association 300 2008 509 519
77. P. Koutkia, B. Canavan, and J. Breu Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial Journal of American Medical Association 292 2004 210 218 (Pubitemid 38917998)
78. Y. Wang, and B. Tomlinson Tesamorelin, a human growth hormone releasing factor analogue Expert Opinion on Investigational Drugs 18 2009 303 310
79. J. Falutz, S. Allas, and D. Kotler A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation AIDS 19 2005 1279 1287 (Pubitemid 41224897)
80. J. Falutz, S. Allas, and K. Blot Metabolic effects of a growth hormone-releasing factor in patients with HIV The New England Journal of Medicine 357 2007 2359 2370 (Pubitemid 350223390)
81. J. Falutz, D. Potvin, and J.C. Mamputu Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension Journal of Acquired Immune Deficiency Syndromes 53 2010 311 322
82. J. Falutz, J.C. Mamputu, and D. Potvin Effects of tesamorelin (TH9507), a growth hormone-releasing factor analog, in human immunodeficiency virus-infected patients with excess abdominal fat: a pooled analysis of two multicenter, double-blind placebo-controlled phase 3 trials with safety extension data The Journal of Clinical Endocrinology and Metabolism 95 2010 4291 4304
83. J. Falutz, S. Allas, and J.C. Mamputu Long-term safety and effects of tesamorelin, a growth hormone-releasing factor analogue, in HIV patients with abdominal fat accumulation AIDS 22 2008 1719 1728